taro-perampanel tablet
taro pharmaceuticals inc - perampanel - tablet - 2mg - perampanel 2mg
taro-perampanel tablet
taro pharmaceuticals inc - perampanel - tablet - 4mg - perampanel 4mg
taro-perampanel tablet
taro pharmaceuticals inc - perampanel - tablet - 6mg - perampanel 6mg
taro-perampanel tablet
taro pharmaceuticals inc - perampanel - tablet - 8mg - perampanel 8mg
taro-perampanel tablet
taro pharmaceuticals inc - perampanel - tablet - 10mg - perampanel 10mg
taro-perampanel tablet
taro pharmaceuticals inc - perampanel - tablet - 12mg - perampanel 12mg
fycompa- perampanel tablet fycompa- perampanel suspension
eisai inc. - perampanel (unii: h821664npk) (perampanel - unii:h821664npk) - perampanel 2 mg - fycompa is indicated for the treatment of partial-onset seizures with or without secondarily generalized seizures in patients with epilepsy 4 years of age and older. fycompa is indicated as adjunctive therapy for the treatment of primary generalized tonic-clonic seizures in patients with epilepsy 12 years of age and older. none. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antiepileptic drugs (aeds), such as fycompa, during pregnancy. encourage women who are taking fycompa during pregnancy to enroll in the north american antiepileptic drug (naaed) pregnancy registry by calling 1-888-233-2334 or visiting http://www.aedpregnancyregistry.org. risk summary there are no adequate data on the developmental risk associated with use in pregnant women. in animal studies, perampanel induced developmental toxicity in pregnant rat and rabbit at clinically relevant doses [ see data ] . in the u.s. general population the estimated background risk
fycompa perampanel (as hemisesquihydrate) 6 mg film coated tablet blister
eisai australia pty ltd - perampanel hemisesquihydrate, quantity: 6.2 mg (equivalent: perampanel, qty 6 mg) - tablet, film coated - excipient ingredients: titanium dioxide; macrogol 8000; hypromellose; purified talc; lactose monohydrate; microcrystalline cellulose; iron oxide red; magnesium stearate; povidone - fycompa is indicated for the adjunctive treatment of:,1) partial-onset seizures (pos) with or without secondarily generalised seizures in patients from 4 years of age with epilepsy.,2) primary generalised tonic-clonic seizures (pgtcs) in patients from 7 years of age with idiopathic generalised epilepsy.
fycompa perampanel (as hemisesquihydrate) 10 mg film coated tablet blister
eisai australia pty ltd - perampanel hemisesquihydrate, quantity: 10.4 mg (equivalent: perampanel, qty 10 mg) - tablet, film coated - excipient ingredients: purified talc; iron oxide yellow; hypromellose; lactose monohydrate; povidone; indigo carmine aluminium lake; macrogol 8000; titanium dioxide; microcrystalline cellulose; magnesium stearate - fycompa is indicated for the adjunctive treatment of:,1) partial-onset seizures (pos) with or without secondarily generalised seizures in patients from 4 years of age with epilepsy.,2) primary generalised tonic-clonic seizures (pgtcs) in patients from 7 years of age with idiopathic generalised epilepsy.
fycompa perampanel (as hemisesquihydrate) 12 mg film coated tablet blister
eisai australia pty ltd - perampanel hemisesquihydrate, quantity: 12.5 mg (equivalent: perampanel, qty 12 mg) - tablet, film coated - excipient ingredients: hypromellose; povidone; microcrystalline cellulose; indigo carmine aluminium lake; purified talc; magnesium stearate; lactose monohydrate; macrogol 8000; titanium dioxide - fycompa is indicated for the adjunctive treatment of:,1) partial-onset seizures (pos) with or without secondarily generalised seizures in patients from 4 years of age with epilepsy.,2) primary generalised tonic-clonic seizures (pgtcs) in patients from 7 years of age with idiopathic generalised epilepsy.